Clinical Pharmacokinetics
Clinical Pharmacokinetics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 191. It has a price of 3290 €. It has an SJR impact factor of 1,305 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,305.
Clinical Pharmacokinetics focuses its scope in these topics and keywords: pharmacokinetics, pharmacodynamics, subjects, acetate, patients, aspects, disease, evaluation, intramuscular, prednisolone, ...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
1,305
H-index
191
Docs (year)
125
Docs 3y
368
Total refs
5741
Cites 3y
1539
Citable 3y
348
Cites/Doc 2y
3.93
Ref/Doc
45.93
Immediate OA
3290 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Clinical Pharmacokinetics in Patients with Burns
View moreWhole Body Pharmacokinetic Models
View moreClinical Pharmacokinetics of Isoniazid
View moreClinical Pharmacokinetics of Fluconazole in Superficial and Systemic Mycoses
View moreClinical Pharmacokinetics of Fluconazole
View moreClinical Pharmacokinetics of Endocrine Agents Used in Advanced Breast Cancer
View moreClinical Pharmacokinetics of Drugs in Obesity
View moreClinical Pharmacokinetics of Cyclophosphamide
View moreClinical Pharmacokinetics of Co-trimoxazole (trimethoprim-sulphamethoxazole)
View moreClinical Pharmacokinetics of Ceftriaxone
View moreClinical Pharmacokinetics of Carbamazepine
View moreClinical Pharmacokinetics of Aztreonam
View moreClinical Pharmacokinetics of Allopurinol
View moreA Brief Introduction to Monte Carlo Simulation
View moreClinical Pharmacokinetics During Continuous Haemofiltration
View moreClinical Pharmacokinetics and Pharmacology of Trimetrexate
View moreClinical Pharmacokinetics and Pharmacodynamics of the Novel SGLT2 Inhibitor Ipragliflozin
View moreClinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic
View moreClarithromycin Clinical Pharmacokinetics
View moreAuthors' Reply to Coste et al.: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"
View moreAugmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch
View moreApplication of a Systems Approach to the Bottom-Up Assessment of Pharmacokinetics in Obese Patients
View moreApplication of a Gamma Model of Absorption to Oral Cyclosporin
View moreAnimal-to-Human Extrapolation of the Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine
View more